Can Cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?

Renal Failure

Volumn 27, Issue 3, 2005, Pages 247-253

  Ozer, Betul Altay ^a,c   Baykal, Asli ^a   Dursun, Belda ^b   Gultekin, Meral ^a   Suleymanlar, Gultekin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Akdeniz University Medical Faculty Hospital ^*  (United States)

Author keywords

Cystatin C; GFR; MDRD; Primary hypertension

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; CREATININE; CYSTATIN C; NITROGEN; PROTEIN; UREA; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REFERENCE VALUE; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; CYSTATINS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; ROC CURVE; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 20044382469     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200056635     Document Type: Article

References (28)

1. Siewert-Delle, A.; Ljungman, S.; Andersson, O.K.; Wilhelmsen, L. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the primary prevention study in Göteborg, Sweden. Nephrol. Dial. Transplant. 1998, 13, 3084-3090.
2. Luft, F.C. Hypertensive nephrosclerosis-a cause of end-stage renal disease? Nephrol. Dial. Transplant. 2000, 15, 1515-1517.
3. Perrone, R.D.; Madias, N.E.; Levey, A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 1992, 38, 1933-1953.
4. Dharnidharka, V.R.; Kwon, C.; Stevens, G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002, 40 (2), 221-226.
5. Newman, D.J.; Cystatin, C. Ann. Clin. Biochem. 2002, 39, 89-104.
6. Price, C.P.; Finney, H. Developments in the assessment of glomerular filtration rate. Clin. Chim. Acta 2000, 297, 55-66.
7. Laterza, O.P.; Price, C.P.; Scott, M.G. Cystatin C: An improved estimator of glomerular filtration rate. Clin. Chem. 2002, 48 (5), 699-707.
8. Kyhse-Andersen, J.; Schmidt, C.; Nordin, G.; Andersson, B.; Nilsson-Ehle, P.; Lindstrom, V.; Grubb, A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem. 1994, 40, 1921-1926.
9. Finney, H.; Newman, D.J.; Gruber, W.; Merle, P.; Price, C.P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin. Chem. 1997, 43, 1016-1022.
10. Pergande, M.; Jung, K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin. Chem. 1993, 39, 1885-1890.
11. Harmoinen, A.P.; Kouri, T.T.; Wirta, O.R.; Lehtimaki, T.J.; Rantalaiho, V.; Turjanmaa, V.M.; Pasternack A.I. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin. Nephrol. 1999, 52 (6), 363-370.
12. Risch, L.; Blumberg, A.; Huber, A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol. Dial. Transplant. 1999, 14, 1991-1996.
13. Le Bricon, T.; Thervet, E.; Froissart, M.; Benlakehal, M.; Bousquet, B.; Legendre, C.; Erlich, D. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin. Chem. 2000, 46, 1206-1207.
14. Orlando, R.; Mussap, M.; Plebani, M.; Piccoli, P.; De Martin S.; Floreani, M.; Padrini, R.; Palatini, P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin. Chem. 2002, 48, 850-858.
15. Mangge, H.; Liebmann, P.; Tanil, H.; Herrmann, J.; Wagner, C.; Gallistl, S.; Schauenstein, K.; Erwa, W. Cystatin, an early indicator for incipient renal disease in rheumatoid arthritis. Clin. Chim. Acta 2000, 300, 195-202.
16. Kazama, J.J.; Kutsuwada, K.; Ataka, K.; Maruyama, H.; Gejyo, F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002, 91, 13-20.
17. Levey, A.S.; Bosch, J.P.; Lewis, J.B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annu. Intern. Med. 1999, 130, 461-470.
18. Cockcroft, D.W.; Gault, M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16, 31-41.
19. Du Bois, D.; Du Bois, E.F. A formula to estimate the approximate surface area if height and weight are known. Arch. Intern. Med. 1916, 17, 863-871.
20. Zweig, M.H.; Campbell, G. Receiver-operating characteristics (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1999, 39, 561-577.
21. Mussap, M.; Dalla Vestra, M.; Fioretto, P.; Saller, A.; Varagnolo, M.; Nosadini, R.; Plebani, M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002, 61 (4), 1453-1461.
22. Randers, E.; Erlandsen, E.J.; Pedersen, O.L.; Hasling, C.; Danielsen, H. Serum Cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin. Nephrol. 2000, 54 (3), 203-209.
23. Coll, E.; Botey, A.; Alvarez, L.; Poch, E.; Quinto, L.; Saurina, A.; Vera, M.; Piera, C.; Darnell, A. Serum Cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am. J. Kidney Dis. Jul 2000, 36 (1), 29-34.
24. Hoek, F.J.; Kemperman, F.A.W.; Krediet, R.T. A comparison between Cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol. Dial. Transplant. 2003, 18, 2024-2031.
25. Perlemoine, C.; Beauvieux, M.C.; Rigalleau, V.; Baillet, L.; Barthes, N.; Derache, P.; Gin, H. Interest of Cystatin C in screening diabetic patients for early impairment of renal function. Metabolism 2003, 52 (10), 1258-1264.
26. Mussap, M.; Ruzzante, N.; Varagnolo, M.; Plebani, M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human Cystatin C. Clin. Chem. Lab. Med. 1998, 36 (11), 859-865.
27. Watanabe, S.; Okura, T.; Liu, J.; Miyoshi, K.; Fukuoka, T.; Hiwada, K.; Higaki, J. Serum Cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens. Res. Nov 2003, 26 (11), 895-899.
28. Seco, M.L.; Rus, A.; Sierra, M.; Caballero, M.; Borque, L. Determination of serum Cystatin C in patients with essential hypertension. Nephron 1999, 81 (4), 446-447.